Expression of the CCAAT/Enhancer-Binding Proteins C/EBPα, C/EBPβ and C/EBPδ in Breast Cancer: Correlations with Clinicopathologic Parameters and Cell-Cycle Regulatory Proteins
✍ Scribed by Karin Milde-Langosch; Thomas Löning; Ana-Maria Bamberger
- Book ID
- 110442467
- Publisher
- Springer US
- Year
- 2003
- Tongue
- English
- Weight
- 388 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Objective. To investigate the activation and expression of CCAAT/enhancer-binding proteins (C/EBP), especially C/EBP and -␦, in rheumatoid synovium, and their pathogenic implications in rheumatoid arthritis (RA). Methods. The activation of C/EBP and -␦ was assessed in synovial tissues from patient
## Abstract “Loss of function” alterations in growth inhibitory signal transduction pathways are common in cancer cells. In this study, we show that growth arrest (GA) treatments—serum and growth factor withdrawal and growth inhibitory IL‐6 family cytokines (Interleukin‐6 and Oncostatin M (OSM))—in
Regulation of cell differentiation is most often impaired in malignant tumors and may represent a key mechanism for the progression of the disease. CCAAT-enhancer binding protein (C/EBP) is a family of transcription factors involved in the regulation of embryonic gut development in rodents, which ha
## Abstract CCAAT/Enhancer binding proteins (C/EBPs) play important roles in the regulation of cell growth and differentiation. This study investigated the expression and function of C/EBPβ isoforms in the mouse mammary gland, mammary tumors, and a nontransformed mouse mammary epithelial cell line